➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Harvard Business School
Express Scripts
Dow
Baxter

Last Updated: October 19, 2020

DrugPatentWatch Database Preview

ATENOLOL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Atenolol patents expire, and what generic alternatives are available?

Atenolol is a drug marketed by Able, Alvogen, Apothecon, Aurobindo Pharma, Dava Pharms Inc, Hlthcare, Invatech, Ipca Labs Ltd, Mylan, Northstar Hlthcare, Nostrum Labs, Pliva, SCS, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Unichem Labs Ltd, Unique Pharm Labs, Watson Labs, Watson Labs Teva, Zydus Pharms Usa, and Zydus Pharms. and is included in thirty-seven NDAs.

The generic ingredient in ATENOLOL is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.

Drug patent expirations by year for ATENOLOL
Drug Prices for ATENOLOL

See drug prices for ATENOLOL

Drug Sales Revenue Trends for ATENOLOL

See drug sales revenues for ATENOLOL

Recent Clinical Trials for ATENOLOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Onassis Cardiac Surgery CentreN/A
Massachusetts Eye and Ear InfirmaryPhase 2
Centro Universitario de Ciencias de la Salud, MexicoPhase 4

See all ATENOLOL clinical trials

Pharmacology for ATENOLOL
Paragraph IV (Patent) Challenges for ATENOLOL
Tradename Dosage Ingredient NDA Submissiondate
TENORMIN TABLET;ORAL atenolol 018240

US Patents and Regulatory Information for ATENOLOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 073582-002 Apr 29, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc ATENOLOL atenolol TABLET;ORAL 078210-002 Jul 10, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
Northstar Hlthcare ATENOLOL atenolol TABLET;ORAL 078254-003 Sep 25, 2009 DISCN No No   Start Trial   Start Trial   Start Trial
Teva ATENOLOL atenolol TABLET;ORAL 073316-001 May 28, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs Teva ATENOLOL atenolol TABLET;ORAL 073353-001 Dec 27, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
McKinsey
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.